LU files Form 6‑K: Director and Committee Composition Updates

Rhea-AI Filing Summary

Lufax Holding Ltd. filed a Form 6‑K signed by Tongzhuan Xi, its Chief Financial Officer, dated August 14, 2025, to disclose changes in its board and committee composition. The filing includes three exhibits: a press release announcing board and committee changes, a submission to The Stock Exchange of Hong Kong Limited reporting (1) change of directors and (2) changes in the Audit Committee and Nomination and Remuneration Committee, and a list of directors with their roles and functions.

The materials are governance disclosures about director appointments or resignations and related committee reassignments; no financial results, major transactions, or forward guidance are included in the provided text.

Positive

• Timely disclosure of board and committee composition changes via a Form 6‑K
• Includes Exchange filings and a full list of directors with their roles, improving transparency
• Signed by CFO Tongzhuan Xi and dated August 14, 2025, providing clear provenance

Negative

• None.

Insights

Corporate Governance Analyst

Board and committee changes disclosed; governance roles updated.

The filing formally notifies investors that director changes and reconfiguration of the Audit Committee and the Nomination and Remuneration Committee have been documented via a press release and Hong Kong Exchange announcements.

This matters because committee membership affects oversight of financial reporting and executive pay; the filing provides the list of directors and roles, enabling investors to track who holds key governance responsibilities going forward.

Regulatory Filings Specialist

Disclosure complies with listing-reporting practice; date and signer provided.

The Form 6‑K is signed by the CFO, Tongzhuan Xi, and dated August 14, 2025, and attaches Exchange filings as exhibits, indicating timely public disclosure of governance changes to both U.S. and Hong Kong stakeholders.

No financial tables, earnings figures, or transaction details are included in the supplied content, so the filing is limited to governance notification.

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

Form 6-K

REPORT OF FOREIGN PRIVATE ISSUER

PURSUANT TO RULE 13a-16 OR 15d-16 UNDER

THE SECURITIES EXCHANGE ACT OF 1934

For the month of August 2025

Commission File Number 001-39654

Lufax Holding Ltd

(Registrant’s name)

Building No. 6

Lane 2777, Jinxiu East Road

Pudong New District, Shanghai

People’s Republic of China

(Address of principal executive office)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F. Form 20-F ☒ Form 40-F ☐

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

				Lufax Holding Ltd
				By:		/s/ Tongzhuan Xi
				Name:		Tongzhuan Xi
				Title:		Chief Financial Officer
Date: August 14, 2025

Exhibit Index

Exhibit 99.1		—		Press Release—Lufax Announces Changes in Board and Committee Composition
Exhibit 99.2		—		Announcement with The Stock Exchange of Hong Kong Limited— (1) Change of Directors (2) Change in Composition of Audit Committee and Nomination and Remuneration Committee
Exhibit 99.3		—		Announcement with The Stock Exchange of Hong Kong Limited—List of Directors and Their Roles and Functions

FAQ

What did Lufax (LU) disclose in the Form 6‑K dated August 14, 2025?

The company disclosed changes in directors and in the composition of the Audit Committee and the Nomination and Remuneration Committee, with supporting exhibits including a press release and Exchange announcements.

Who signed the Lufax Form 6‑K filing?

The filing is signed by Tongzhuan Xi, the company's Chief Financial Officer.

Does the filing include financial results or major transactions?

No. The provided content contains governance disclosures only and does not include earnings, financial tables, or major transaction details.

What exhibits were attached to the Form 6‑K?

Exhibit 99.1: press release announcing board and committee changes; Exhibit 99.2: Hong Kong Exchange announcement on change of directors and committee composition; Exhibit 99.3: list of directors and their roles.

Is there an updated list of directors and their roles in the filing?

Yes. Exhibit 99.3 is an Exchange filing containing the list of directors and their roles and functions.